Q4 2021 US Reporting Season Preview

Macro Overview

2021 saw the S&P500 hit fresh record highs on an astonishing 70 separate days. It is noticeable that the first two weeks of 2022 have seen a continuation of the volatility that marked the final months of 2021.

US inflation recently reached an almost 40 year high, hitting an annualised 7% in December. To counter this, the Federal Reserve has become increasingly hawkish.

In response, market expectations have shifted towards faster balance sheet normalization, with "quantitative tightening" to begin in September after Fed lift-off in June or possibly as early as March. A prospect that has rattled tech stocks.

Meanwhile, surging Omicron cases have left hospitals straining under the weight of numbers, disrupting global supply chains and grocery shelves empty. A development that will weigh on Q1 growth, likely to be reflected in some company's forward guidance.

Earnings

Despite the headwinds outlined above, S&P500 companies are expected to deliver strong earnings growth again. According to Factset, "For Q4 2021, the estimated earnings growth rate for the S&P 500 is 21.7%."

Presuming this is the confirmed growth rate for the quarter, it will mark the fourth straight quarter of earnings growth above 20% and lift full years earning growth to more than 40% for the full year.

Guidance

As noted by FactSet in the first week of January, "93 S&P 500 companies have issued EPS guidance for the fourth quarter. This number is slightly below the 5-year average of 100. Of these 93 companies, 56 have issued negative EPS guidance, and 37 have issued positive EPS guidance."

This marks the first time since Q2 2020 that S&P500 companies have issued more negative EPS guidance than positive guidance. Despite this, the estimated (year over year) earnings growth for Q4 2021 is above the expectations from the start of Q4.

Sector Performance

As noted by Factset, the Energy sector led by companies such as Exxon Mobil and Chevron have recorded the largest percentage increase in estimated (dollar-level) earnings of all eleven sectors since the start of the quarter at 40.8% (to $28.1 billion from $20.0 billion).

The Consumer Discretionary sector led by Amazon.com has recorded the largest percentage decrease in estimated (dollar-level) earnings of all eleven sectors since the start of the quarter at -15.1% (to $27.1 billion from $32.0 billion).

S&P500 Technical Outlook

The overnight decline has the S&P500 eyeing important trendline support at 4620/00ish from the March 2020, 2174 low.

Providing the S&P500 remains above 4620/00 (closing basis), look for a push towards 5000 during the first quarter of 2022.

However, should a sustained break below 4620/00ish occur, the risks are for a deeper pullback towards 4400.

Source Tradingview. The figures stated areas of January 14th, 2022. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation

How to trade with City Index

You can trade with City Index by following these four easy steps:

Open an account, or log in if you’re already a customer

• Open an account in the UK
• Open an account in Australia
• Open an account in Singapore
Search for the company you want to trade in our award-winning platform
Choose your position and size, and your stop and limit levels
Place the trade

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.